CleanSlate Outpatient Addiction Medicine Announces New Chief Clinical Officer
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Mar 14, 2019--CleanSlate Outpatient Addiction Medicine, a national leader in office-based opioid and alcohol use disorder treatment, today announced the appointment of Tracey Cohen, MD as Chief Clinical Officer as the company continues to expand to meet the growing demand for high quality, evidence-based addiction medicine.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190314005170/en/
Dr. Tracey Cohen is the Chief Clinical Officer at CleanSlate Outpatient Addiction Medicine, which is the nation’s fastest-growing national medical group that provides evidence-based, medication-assisted treatment and holistic care to treat the disease of addiction in an outpatient setting. CleanSlate primarily treats patients for opioid and alcohol use disorder. (Photo: Business Wire)
Board certified in Family and Addiction Medicine, Cohen is widely recognized as a leader in health care integration, substance use disorder care, primary care, chronic pain, and safe, appropriate pharmacy utilization. Her high-impact initiatives in these areas have served as regional and national models. Prior to serving as CCO, Dr. Cohen spent seven years as a part-time physician at CleanSlate. She will operate out of CleanSlate’s New Bedford center in Massachusetts where she will continue to provide hands-on treatment to patients, in addition to her role as CCO.
“CleanSlate has grown significantly over the past few years to better serve patients across the country in need of high-quality addiction treatment, and we are constantly working to expand patient access to effective addiction medicine,” said Gregory Marotta, CleanSlate President and Chief Executive Officer. “Dr. Cohen will lead our clinical efforts to achieve our vision of transforming outpatient addiction medicine as we expand our integrated medical and behavioral health model in our centers to improve physical and behavioral health outcomes among people living with mental illnesses and addiction, as well as to lower the cost of care associated with this complex patient population. Her in-depth knowledge of community-based behavioral and addiction health care, coupled with her keen business savvy, will help position CleanSlate to continue being a leader in evidence-based addiction treatment and a strong partner in the communities that we serve.”
Dr. Cohen is a physician executive with more than 17 years of clinical and business experience leading health care organizations to relevant and sustained progress in quality and value. Prior to joining CleanSlate, she served as Medical Director of Neighborhood Health Plan of Rhode Island, named one of the top Medicaid health plans nationally and serving more than 200,000 members. There she managed behavioral health care and health care integration as she did in her prior role as Medical Director of Behavioral Health and Quality at Blue Cross Blue Shield of Rhode Island, 2013-2015. Cohen received her medical degree from the University of Pennsylvania School of Medicine, where she was named a Twenty-First Century Scholar, and conducted her residency in Family Medicine at Brown University.
As CCO, Dr. Cohen will use both her clinical expertise and business acumen to oversee management of medical staff and guide and engage CleanSlate’s physicians, nurse practitioners, physician assistants, and clinical staff. As the primary clinical voice for care model strategy and program development decisions, she will drive quality and promote clinical effectiveness, aligning care across the company and wielding influence throughout all service lines.
“I’m thrilled to join CleanSlate in its mission to provide superior access to high-quality, integrated addiction care. CleanSlate is unique in how we meet people where they are and support each individual’s path in recovery,” said Dr. Cohen. “As Chief Clinical Officer, I look forward to continuing the evolvement of our treatment model as one that empowers patients on their journey to improve wellness by providing evidence-based behavioral and medical care that supports the whole person and addresses all aspects of their addiction.”
CleanSlate Outpatient Addiction Medicine helps patients achieve recovery from opioid use disorder and alcohol use disorder in 10 states through 56 outpatient addiction medicine centers. For more information about CleanSlate, visit cleanslatecenters.com.
About CleanSlate Outpatient Addiction Medicine
A pioneer and leader in outpatient addiction medicine, CleanSlate Outpatient Addiction Medicine is a national medical group which provides treatment for the chronic disease of addiction, primarily opioid and alcohol use disorders. Founded in 2009 in response to the growing opioid epidemic facing the country, the company is a growing, multi-state network of physician-led outpatient addiction treatment centers where patients who have addiction and associated disorders can receive medication-assisted treatment and related therapies using the highest quality, evidence-based practices.
For more information, please visit CleanSlateCenters.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190314005170/en/
CONTACT: Carol Fite Lynn
KEYWORD: UNITED STATES NORTH AMERICA TENNESSEE
INDUSTRY KEYWORD: HEALTH MENTAL HEALTH PHARMACEUTICAL
SOURCE: CleanSlate Outpatient Addiction Medicine
Copyright Business Wire 2019.
PUB: 03/14/2019 09:00 AM/DISC: 03/14/2019 09:00 AM